Apotea AB (publ), a prominent player in the Consumer Staples sector, operates as an online pharmacy in Sweden, offering a comprehensive range of health and wellness products. The company is listed on the Swedish Stock Exchange and trades in SEK. As of July 14, 2026, Apotea’s close price was recorded at 74.35 SEK, with a 52-week high of 122 SEK on July 27, 2025, and a 52-week low of 54.42 SEK on March 18, 2026. The company boasts a market capitalization of 7,836,544,000 SEK.

Founded in 2011 and headquartered in Stockholm, Apotea has established itself as a versatile provider of pharmaceutical and health-related products. Its product portfolio spans various categories, including allergy, face, baby, child and parent care, bite and sting remedies, preparedness, animal health, fever and aches, cold and flu, home and household aids, hair removal and shaving, hair care, hands and feet, intimate care, and dietary supplements. Additionally, Apotea offers products for body care, stomach and intestine health, food and drink, mouth and teeth care, premium health products, travel essentials, sexual health, smoking cessation aids, makeup, sun protection, wound care, sleep aids, training supplements, weight control, vitamins and minerals, charity products, and eye and ear care.

Beyond its extensive product offerings, Apotea engages in leasing and hiring out personnel to related companies, enhancing its operational capabilities. The company also contributes to marketing efforts, further solidifying its presence in the competitive online pharmacy market. With a robust product range and strategic business operations, Apotea continues to serve as a key player in Sweden’s health and wellness sector.